Source:http://linkedlifedata.com/resource/pubmed/id/21281998
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1873-1570
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
498
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21281998-Child,
pubmed-meshheading:21281998-Critical Care,
pubmed-meshheading:21281998-Critical Illness,
pubmed-meshheading:21281998-Dose-Response Relationship, Drug,
pubmed-meshheading:21281998-Humans,
pubmed-meshheading:21281998-Hypoglycemic Agents,
pubmed-meshheading:21281998-Insulin,
pubmed-meshheading:21281998-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Intensive insulin therapy in critically ill children: it is time for outlining a protocol.
|
pubmed:publicationType |
Letter
|